PUBLICATIONS · 27217448
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2016 Jul 10
- First author
- Cortes JE
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2017 Feb 10;35(5):567. doi: 10.1200/JCO.2016.69.5940.
- note
- Source null
- related pmid
- 29236617
- relationship
- Comment in
- citation
- J Clin Oncol. 2017 Feb 10;35(5):567-568. doi: 10.1200/JCO.2016.70.2944.
- note
- Source null
- related pmid
- 29236618
- relationship
- Comment in
Authors and identifiers
- name
- Cortes JE
- type
- Author
- name
- Saglio G
- type
- Author
- name
- Kantarjian HM
- type
- Author
- name
- Baccarani M
- type
- Author
- name
- Mayer J
- type
- Author
- name
- Boqué C
- type
- Author
- name
- Shah NP
- type
- Author
- name
- Chuah C
- type
- Author
- name
- Casanova L
- type
- Author
- name
- Bradley-Garelik B
- type
- Author
- name
- Manos G
- type
- Author
- name
- Hochhaus A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Cortes JE
- type
- Author
- name
- Saglio G
- type
- Author
- name
- Kantarjian HM
- type
- Author
- name
- Baccarani M
- type
- Author
- name
- Mayer J
- type
- Author
- name
- Boqué C
- type
- Author
- name
- Shah NP
- type
- Author
- name
- Chuah C
- type
- Author
- name
- Casanova L
- type
- Author
- name
- Bradley-Garelik B
- type
- Author
- name
- Manos G
- type
- Author
- name
- Hochhaus A
- type
- Author
- bibliography ids
- nci-bib-a56868c32acea0117e7ff182
- book metadata
- content sha256
- 533c397da78f713f8120e0f705e4675610bc45884e8871beff5075baade40841
- document type
- citation
- dois
- 10.1200/JCO.2015.64.8899
- electronic publication date
- display
- 2016 May 23
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27217448
- immutable id
- pubmed:27217448@533c397da78f713f8120e0f705e4675610bc45884e8871beff5075baade40841
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 20
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2333-40
- volume
- 34
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2017 Feb 10;35(5):567. doi: 10.1200/JCO.2016.69.5940.
- note
- Source null
- related pmid
- 29236617
- relationship
- Comment in
- citation
- J Clin Oncol. 2017 Feb 10;35(5):567-568. doi: 10.1200/JCO.2016.70.2944.
- note
- Source null
- related pmid
- 29236618
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 27217448
- provenance
- batch id
- fe5a46c92522c34737e8
- provider
- NCBI PubMed ESummary
- record sha256
- 4a7f60c20664fa06cd72560362cbe0a4685814ad5087d1690ceaadd9ebc2374c
- response sha256
- 2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
- retrieved at
- 2026-09-09T23:47:17.939307+00:00
- publication date
- display
- 2016 Jul 10
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.
Preserved source evidence · Not medical advice
Triangle